All Stories

  1. A conserved role for AKT in the replication of emerging flaviviruses in vertebrates and vectors

    Article • Virus Research, October 2024, Elsevier

    Antonio Mas

  2. Mathematical modeling of the waning of anti-RBD IgG SARS-CoV-2 antibody titers after a two-dose BNT162b2 mRNA vaccination

    Article • August 2022, Cold Spring Harbor Laboratory Press

    Antonio Mas

  3. Effectiveness of Silver Nanoparticles Deposited in Facemask Material for Neutralising Viruses

    Article • Nanomaterials, August 2022, MDPI AG

    Antonio Mas

  4. Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools

    Article • PLoS Pathogens, January 2022, PLOS

    Antonio Mas

  5. Akt Phosphorylation of Hepatitis C Virus NS5B Regulates Polymerase Activity and Hepatitis C Virus Infection

    Article • Frontiers in Microbiology, October 2021, Frontiers

    Antonio Mas

  6. Akt Kinase Intervenes in Flavivirus Replication by Interacting with Viral Protein NS5

    Article • Viruses, May 2021, MDPI AG

    Antonio Mas

  7. Akt Interacts with Usutu Virus Polymerase, and Its Activity Modulates Viral Replication

    Article • Pathogens, February 2021, MDPI AG

    Antonio Mas

  8. Polymerase Activity, Protein-Protein Interaction, and Cellular Localization of the Usutu Virus NS5 Protein

    Article • Antimicrobial Agents and Chemotherapy, December 2019, ASM Journals

    Antonio Mas

  9. Highly heterogeneous mutation rates in the hepatitis C virus genome

    Article • Nature Microbiology, April 2016, Nature

    Antonio Mas

  10. Hepatitis C Virus RNA-Dependent RNA Polymerase Interacts with the Akt/PKB Kinase and Induces Its Subcellular Relocalization

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Antonio Mas

  11. Hepatitis E Virus in Industrialized Countries: The Silent Threat

    Article • BioMed Research International, January 2016, Hindawi Publishing Corporation

    Antonio Mas

  12. Exploiting the potential of autophagy in cisplatin therapy: A new strategy to overcome resistance

    Article • Oncotarget, May 2015, Impact Journals, LLC

    Antonio Mas

  13. Hepatitis C virus polymerase–polymerase contact interface: Significance for virus replication and antiviral design

    Article • Antiviral Research, August 2014, Elsevier

    Antonio Mas

  14. Characterization of the interaction between hepatitis C virus NS5B and the human oestrogen receptor alpha

    Article • Journal of General Virology, April 2012, Society for General Microbiology

    Antonio Mas

  15. Quasispecies as a matter of fact: Viruses and beyond

    Article • Virus Research, December 2011, Elsevier

    Antonio Mas

  16. Study of NS5B Oligomerization by FRET: Characterization and Inhibition

    Article • Antiviral Research, May 2011, Elsevier

    Antonio Mas

  17. De Novo Polymerase Activity and Oligomerization of Hepatitis C Virus RNA-Dependent RNA-Polymerases from Genotypes 1 to 5

    Article • PLoS ONE, April 2011, PLOS

    Antonio Mas

  18. Population Diversity and its Relationship with Infectious and Tumor Diseases

    Article • Current Immunology Reviews, February 2011, Bentham Science Publishers

    Antonio Mas

  19. Monitoring hepatitis C virus (HCV) RNA-dependent RNA polymerase oligomerization by a FRET-based in vitro system

    Article • Antiviral Research, July 2010, Elsevier

    Antonio Mas

  20. Unfinished Stories on Viral Quasispecies and Darwinian Views of Evolution

    Article • Journal of Molecular Biology, April 2010, Elsevier

    Antonio Mas

  21. LSm1-7 complexes bind to specific sites in viral RNA genomes and regulate their translation and replication

    Article • RNA, February 2010, Cold Spring Harbor Laboratory Press

    Antonio Mas

  22. Xenopus Xp54 and Human RCK/p54 Helicases Functionally Replace Yeast Dhh1p in Brome Mosaic Virus RNA Replication

    Article • Journal of Virology, February 2007, ASM Journals

    Antonio Mas

  23. Information catastrophe in RNA viruses through replication thresholds

    Article • Journal of Theoretical Biology, June 2006, Elsevier

    Antonio Mas

  24. Host Deadenylation-Dependent mRNA Decapping Factors Are Required for a Key Step in Brome Mosaic Virus RNA Replication

    Article • Journal of Virology, January 2006, ASM Journals

    Antonio Mas

  25. Hepatitis C virus population analysis of a single-source nosocomial outbreak reveals an inverse correlation between viral load and quasispecies complexity

    Article • Journal of General Virology, December 2004, Society for General Microbiology

    Antonio Mas

  26. Similar HIV‐1 evolution and immunological responses at 10 years despite several therapeutic strategies and host HLA Types

    Article • Journal of Medical Virology, June 2004, Wiley

    Antonio Mas

  27. Long‐term suppression of plasma viremia with highly active antiretroviral therapy despite virus evolution and very limited selection of drug‐resistant genotypes

    Article • Journal of Medical Virology, May 2004, Wiley

    Antonio Mas

  28. Molecular Determinants of Multi-nucleoside Analogue Resistance in HIV-1 Reverse Transcriptases Containing a Dipeptide Insertion in the Fingers Subdomain: EFFECT OF MUTATIONS D67N AND T215Y ON REMOVAL OF THYMIDINE NUCLEOTIDE ANALOGUES FROM BLOCKED DNA P...

    Article • Journal of Biological Chemistry, March 2004, American Society for Biochemistry & Molecular Biology (ASBMB)

    Antonio Mas

  29. Insertions in the Reverse Transcriptase Increase both Drug Resistance and Viral Fitness in a Human Immunodeficiency Virus Type 1 Isolate Harboring the Multi-Nucleoside Reverse Transcriptase Inhibitor Resistance 69 Insertion Complex Mutation

    Article • Journal of Virology, October 2002, ASM Journals

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  30. Multidrug-resistant HIV-1 Reverse Transcriptase: Involvement of Ribonucleotide-dependent Phosphorolysis in Cross-resistance to Nucleoside Analogue Inhibitors

    Article • Journal of Molecular Biology, October 2002, Elsevier

    Antonio Mas

  31. Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains

    Article • Journal of Biological Chemistry, May 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  32. Virus population dynamics, fitness variations and the control of viral disease: an update

    Article • January 2001, Springer Science + Business Media

    Antonio Mas

  33. Prevalence and Genetic Heterogeneity of the Reverse Transcriptase T69S-S-X Insertion in Pretreated HIV-Infected Patients

    Article • Intervirology, January 2001, Karger Publishers

    Antonio Mas, Dr. Vicente Soriano

  34. Role of a dipeptide insertion between codons 69 and 70 of HIV-1 reverse transcriptase in the mechanism of AZT resistance

    Article • The EMBO Journal, November 2000, Wiley

    Antonio Mas, Dr. Vicente Soriano

  35. Dynamics of dominance of a dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy

    Article • Virus Research, January 2000, Elsevier

    Antonio Mas, Dr. Vicente Soriano

  36. Prognostic Value of a CCR5 Defective Allele in Pediatric HIV-1 Infection

    Article • Molecular Medicine, January 2000, Springer Science + Business Media

    Antonio Mas

  37. Phylogeny of HIV Type 1 Group O Isolates Based on env Gene Sequences

    Article • AIDS Research and Human Retroviruses, May 1999, Mary Ann Liebert Inc

    Antonio Mas, Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  38. V3-loop and nef gene sequences of HIV-1 isolates from a hemophiliac cohort with long-term non-progressive infection

    Article • AIDS, March 1999, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Antonio Mas

  39. CCR5 genotype and HIV-1 infection in perinatally-exposed infants

    Article • Journal of Infection, January 1999, Elsevier

    Dr. Vicente Soriano, Antonio Mas

  40. LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression

    Article • Virus Research, September 1998, Elsevier

    Antonio Mas, Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  41. Tropism, Coreceptor Use, and Phylogenetic Analysis of Both the V3 Loop and the Protease Gene of Three Novel HIV-1 Group O Isolates

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, August 1998, Wolters Kluwer Health

    Dr Alejandro Vallejo, Antonio Mas, Dr. Vicente Soriano

  42. The decline in CD4+ T lymphocytes as a function of the duration of HIV infection, age at seroconversion, and viral load

    Article • Journal of Infection, May 1998, Elsevier

    Dr. Vicente Soriano, Antonio Mas

  43. Letter to the Editor : Phylogenetic Analysis of HIV Type 2 Strains from Portugal

    Article • AIDS Research and Human Retroviruses, April 1998, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Antonio Mas

  44. Epinephrine-Induced Reduction in Insulin Receptor mRNA Level and Stability in U-937 Human Promonocytic Cells

    Article • Hormone and Metabolic Research, March 1998, Thieme Publishing Group

    Antonio Mas

  45. Cytotoxic T-Lymphocyte Responses to HIV-1 Reverse Transcriptase (Review)

    Article • Viral Immunology, January 1998, Mary Ann Liebert Inc

    Antonio Mas

  46. A pilot study on the efficacy of escalating dosage of alpha-interferon for chronic hepatitis C in HIV-infected patients

    Article • Journal of Infection, November 1997, Elsevier

    Dr. Vicente Soriano, Antonio Mas

  47. Genetic Analysis of an HIV Type 2 Subtype B Virus from a Spanish Individual with AIDS

    Article • AIDS Research and Human Retroviruses, July 1997, Mary Ann Liebert Inc

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Antonio Mas

  48. Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections

    Article • Transfusion Science, March 1997, Elsevier

    Dr. Vicente Soriano, Antonio Mas

  49. Reliability of a new recombinant immunoblot assay (RIBA HIV-1/HIV-2 SIA) as a supplemental (confirmatory) test for HIV-1 and HIV-2 infections

    Article • Transfusion Science, March 1997, Elsevier

    Antonio Mas

  50. Long-term zidovudine responders: is there still rationale for HIV monotherapy?

    Article • AIDS, December 1996, Wolters Kluwer Health

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Antonio Mas

  51. Lack of evidence for viral clearance in children born to HIV-infected mothers

    Article • AIDS, December 1996, Wolters Kluwer Health

    Dr. Vicente Soriano, Antonio Mas

  52. Sequence Note : env Gene Characterization of the First HIV Type 1 Group O Spanish Isolate

    Article • AIDS Research and Human Retroviruses, November 1996, Mary Ann Liebert Inc

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  53. Interferon   for the Treatment of Chronic Hepatitis C in Patients Infected with Human Immunodeficiency Virus

    Article • Clinical Infectious Diseases, September 1996, Oxford University Press (OUP)

    Dr. Vicente Soriano, Antonio Mas

  54. Prevalence of zidovudine-resistant HIV-1 among rapid progressors

    Article • AIDS, September 1996, Wolters Kluwer Health

    Dr. Vicente Soriano, Antonio Mas

  55. First Case of HIV-1 Group O Infection in Spain

    Article • Vox Sanguinis, July 1996, Wiley

    Dr. Vicente Soriano, Antonio Mas

  56. Serial Dilutions on Synthetic Peptide-Based Assays Can Resolve Dual Seroreactivity to HIV-1 and HIV-2

    Article • Vox Sanguinis, July 1996, Wiley

    Dr. Vicente Soriano, Antonio Mas

  57. Hepatitis C viraemia in HIV-infected patients

    Article • AIDS, July 1996, Wolters Kluwer Health

    Dr. Vicente Soriano, Antonio Mas

  58. Epidemiology of HIV-2 infection in Spain

    Article • European Journal of Clinical Microbiology & Infectious Diseases, May 1996, Springer Science + Business Media

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Enrique J. Calderon, Antonio Mas

  59. Circulating HIV-1 Serotypes in Spain

    Article • Vox Sanguinis, May 1996, Wiley

    Dr. Vicente Soriano, Antonio Mas

  60. Detection of Herpesvirus Type 8 (HHV-8) Sequences in Patients with Kaposi's Sarcoma in Spain

    Article • Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology, March 1996, Wolters Kluwer Health

    Dr. Vicente Soriano, Antonio Mas

  61. Hepatitis C Virus Genotypes in Different Risk Populations in Spain

    Article • The Journal of Infectious Diseases, February 1996, Oxford University Press (OUP)

    Dr. Vicente Soriano, Antonio Mas

  62. Epidemiology of HTLV-I Infection in Spain

    Article • International Journal of Epidemiology, January 1996, Oxford University Press (OUP)

    Dr Alejandro Vallejo, Dr. Vicente Soriano, Antonio Mas

  63. Impact of Immunosuppression Caused by HIV Infection on the Replication of Hepatitis C Virus

    Article • Vox Sanguinis, October 1995, Wiley

    Dr. Vicente Soriano, Antonio Mas

  64. The Effect of 1,25-Dihydroxyvitamin D3 on Insulin Binding, Insulin Receptor mRNA Levels, and Isotype RNA Pattern in U-937 Human Promonocytic Cells

    Article • Experimental Cell Research, April 1995, Elsevier

    Antonio Mas

  65. Tissue-Specific Changes in Insulin Receptor mRNA Concentrations in Dexamethasone-Treated and Adrenalectomized Rats.

    Article • Endocrine Journal, January 1994, Japan Endocrine Society

    Antonio Mas